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Abstract SSTR3, a somatostatin (SST) receptor, is an adenylyl 
cyclase (AC)-inhibiting receptor. To assign the G-protein a-
subunit (Ga) linked to this receptor, we created a novel reporter 
system which utilizes the well-established facts that the C-
terminal 5 residues of Ga are the receptor contact site and Gets 
stimulates all subtypes of AC. We constructed chimeric Gag the 
C-terminal 5 residues of which were replaced with the 
corresponding C-terminus of each known Ga, and examined 
which chimera confers SSTR3-induced activation of AC. 
Cellular transfection of SSTR3 and measurement of SST-
dependent AC activity through co-transfected chimeric GOs 
revealed that SSTR3 recognizes the C-termini of GrXji/2 but not 
of GOQ or Gaz, and those of GaM and Gai6, but not of GOq or 
Gan. As predicted by the chimeric Gas, SST-bound SSTR3 
stimulated polyphosphoinositide turnover only when Gai6 or 
Gai4 was co-transfected. We conclude that the chimeric Gag 
system provides a new approach towards the assignment of G-
proteins linked to a given receptor. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Somatostatin (SST) is a 14-amino acid cyclic peptide which 
is the major physiological inhibitor of GH secretion from the 
pituitary [1] and involved in the regulation of insulin and 
glucagon secretion from the pancreatic islets [2]. In addition, 
SST has a role in modulating motor activity and cognitive 
processes in the central nervous system [3,4]. The diverse bio-
logical actions of SST are mediated by specific receptors. SST 
receptors consist of at least five subtypes, all of which possess 
a heptahelical architecture, suggesting that they are the recep-
tors coupled to G-proteins. It has been inferred that they all 
suppress AC (adenylyl cyclase); however, there has been some 
dispute about several of them [5]. Among these receptors, 
SSTR3 (the type 3 receptor) is the best characterized receptor 
that can definitely inhibit AC. However, it remains unclear 
which member of the G; family (Ga;, Ga0 , Gaz) is involved 
in SSTR3-mediated inhibition of AC or what other Ga family 
may couple to this SST receptor. 
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G-proteins link cell surface receptors to various biological 
functions which include hormone action, neurotransmission, 
and chemotaxis, as well as perception of light, smell, and taste 
[6]. This transducer family consists of various Ga gene prod-
ucts. Their members are classified into two categories: one 
group is a family of sensory organ-specific G-proteins (Ga t , 
Gaoif, and Gaglist), and the other is a less tissue-specific class 
(Go.,, three Ga;, two GaD, Gaz , Gaq , G a n , Gai2, Gai3, 
GaM, and Ga^ ) . As for the generic G-coupled receptors, 
determining the linked Ga of the latter subclass is most im-
portant in assessing the signal. However, the Ga assignment 
has not been simple, because (i) there are many Ga proteins 
inside the cell, each similar but distinct; (ii) only a few bio-
chemical effects are known as the outputs of Ga; (iii) those 
known outputs are shared by many Ga; and (iv) most recep-
tors couple to multiple Ga. 
Among the few established outputs of Ga, stimulation of 
AC has been established as the direct effect of the Gs family; 
no other Ga can directly activate AC; and either type of AC 
is stimulated by Ga s . These features allow the monitoring of 
Ga s activity in vivo by measuring the cAMP production. 
However, quite a few receptors do not activate Ga s ; assess-
ment of the G-protein coupling of receptors based upon AC 
stimulation can only be made infrequently. 
On the other hand, it has been accepted that the C-terminus 
of Ga is a site contacted by receptors. Conklin et al. [7] have 
shown that C-terminal 4-5 residues of Ga; are the minimal 
requirement for specific recognition by G;-coupled receptors. 
Voyno-Yasenetskaya et al. [8] converted the coupling of the 
Gai-specific D2 receptor to Gai 3 coupling by expressing the 
Gai3 chimera having the C-terminal 5 residues of Ga;. Liu et 
al. [9] also concluded that the C-terminal 5 residue region of 
Ga is an essential site for receptor contact. In contrast, the 
effector contact sites have been located more N-terminally in 
Ga s [10,11]. Conclusions made by these earlier studies suggest 
that a GOL, chimera (Gas/ax) having the C-terminal 5 residues 
of a Ga subunit (GOx, x = any) alters the output of Gax-
coupled receptors to stimulate AC. 
We created various chimeric Ga s , referred to as Ga s /ax , the 
C-terminal 5 residues of which were replaced with the corre-
sponding C-terminus of each known Ga. We hypothesized 
that the G-protein coupling specificity of any AC-non-stimu-
lating receptor is precisely assigned by expressing each of the 
chimeras to observe cAMP increase by the receptor ligand. If 
a receptor of interest is coupled to Gax , the ligand-bound 
receptor should recognize and activate the co-transfected 
Ga s /ax and cause paradoxical stimulation of AC. Therefore, 
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one could know that the receptor has recognized the C-termi-
nus of a particular Goix, by measuring the agonist-dependent 
increase in c A M P in cells expressing the receptor and the 
cognate G a s / a x . 
In this study, we tested this hypothesis and the utility of 
these chimeras. As described above, SSTR3 is an established 
Gj-linked receptor. Therefore, we examined whether SSTR3 
stimulates A C through the mediation by Gas/oc;, as expected, 
and whether SSTR3 recognizes the chimera with Goc0 or Gocz, 
which is another Got capable of inhibiting AC. We also exam-
ined whether other constructs of these chimeras can predict 
the novel G-coupling capacity of SSTR3. Our chimeric G a s 
system correctly indicated the Goti-coupling function of 
SSTR3 and correctly predicted its so far unknown ability 
coupling to two non-Gcxq members of the G q family G-pro-
tein. Here, by extension of well-established G-protein proper-
ties, we have established a novel system that reports the G-
protein specificity of a given receptor. 
2. Material and methods 
Human SSTR3 DNA encoded in the cytomegalovirus promoter-
driven expression vector pCMV6 have been described [16]. The con-
struction of Ga s chimeras using PCR was described previously [12]. 
Some of the nucleotides used for the construction of Ga s chimeras 
were described in [12]. Several which were not included are: 
for GaB/ai TTAAGAGATTGCGGCTTATTTTAAT 
CTAGATTAAAATAAGCCGCAATCTC 
for Ga s /aq TTAAGAGAGTACAACCTCGTTTAAT 
CTAGATTAAACGAGGTTGTACTCTC 
for GaB/ai2 TTAAGAGATATCATGCTTCAATAAT 
CTAGATTATTGAAGCATGATATCTC 
for GaB/a13 TTAAGACAACTCATGCTTGAATAAT 
CTAGATTATTCAAGCATGAGTTGTC 
for GaB/ai4 TTAAGAGAATTCAACTTAGTTTAAT 
CTAGATTAAACTAAGTTGAATTCTC 
for GaB/a16 TTAAGAGAGATCAATTTGTTGTAAT 
CTAGATTACAACAAATTGATCTCTC 
The final products were verified by sequencing. Rat PTHR (PTH/ 
PTHRP receptor) cDNA was provided by Dr. Gino V. Segre. SST-
14, referred to as SST here, and PTH 1-34 were from Sigma. 
The COS cells were described previously [13]. Transient transfection 
was performed by the standard lipofection method [13]. Cells (2x 104) 
were seeded onto a 24-well plate and cultured in complete growth 
media for 24 h, transfected with 0.25 ug cDNA (0.125 ug SSTR 
DNA and 0.125 ug chimera cDNA) and 1 ul of LipofectAMINE 
for another 24 h in serum-free DMEM, and cultured in complete 
growth media for an additional 24 h. The total amount of DNAs 
was adjusted by an empty plasmid to be 0.25 ug. As G-protein signals 
inhibit the transcriptional activity of various promoters that have 
been used for standardization [14], we did not employ the standard-
ization with the reference genes. However, the reproducibility of the 
cAMP results in SSTR-/chimera-transfected cells between assays and 
between transfections was excellent, as described in Section 3. 
AC activity was assessed by measuring cAMP formation, as de-
scribed [13]. Twenty-four hours after transfection, cells were labeled 
with 6 uCi/ml of [3H]adenine (Du Pont-NEN) for 24 h, and then 
treated with agonists and 1 mM IBMX for 30 min. The cAMP pro-
duced was assayed using two-step ion-exchange columns, and specific 
accumulation of cAMP was expressed as [cAMP/(ADP+ATP)]X 103, 
which represent intact-cell AC activity. PI (polyphosphoinositide) 
turnover was assessed by measuring IP production. Cells were seeded 
at 4 x 104 onto a 24-well plate, cultured in complete growth medium 
for 24 h, and transfected with plasmids for 24 h. The culture medium 
was changed to the labeling medium [inositol-free RPMI + dialyzed 
fetal calf serum and 10 uCi/ml of [3H]myo-inositol (Du Pont-NEN)]; 
and cells were incubated with this medium for 12 h at 37°C. Cells 
were then washed 4 times with inositol-free RPMI and treated with 
1 ul of SST in inositol-free RPMI for 5 min at 37°C. Cells in 0.2 ml 
media were lysed by adding 0.8 ml of ice-cold 12.5% (final 10%) TCA, 
and the sample was then put on ice for 20 min. The supernatant was 
mixed well with 1 ml of saturated diethyl ether to extract acid. After 
repeating extraction 5 times, the collected sample was neutralized with 
1:100 dilution of concentrated ammonia, and then added to 4 ml of 
water. These samples were analyzed by the method [15] using Dowex 
columns. The quantity of PI turnover was assessed with the produc-
tion of inositol phosphates. Statistical analysis was performed with 
Student's t test with P < 0.05 accepted as statistically significant. 
3. Results and discussion 
We constructed G a s chimeras consisting of the Gccs resi-
dues 1-389, which lacks the original five residues of Gocs at 
the C-terminus, and the C-terminal 5 residues of each known 
Got (Fig. 1A). The C-terminal 5 residues are identical between 
Gctii and G o ^ , between G a 0 i and Goc02, and between Gocq 
and G a i i . They were designated Gas/oCi, G a s / a 0 , Gas/ocz, 
Gocs/aq, G a s / a i 2 , Gas/oci3, G a s / a i 4 , and Ga s / d i6 , respec-
tively. Each of the Gocs chimeras was expressed as a 52-kDa 
protein to similar degrees in COS cells (Fig. IB), the expres-
sion level of which was incomparably higher than the endog-
enous Gocs. SSTR3 was expressed in COS cells, as described 
previously [16]. In chimera-transfected cells without SSTR3 
transfection, SST had no effect on A C up to 1 u M . Basal 
A C activity in cells transfected with an empty plasmid or 
SSTR3 c D N A was 1.4 ±0 .1 or 1.610.3 [cAMP/ 
( A D P + A T P ) X 103, m e a n i S E of four independent transfec-
tions], respectively. Thus, significant increases in basal A C 
were observed in cells transfected with every G a s / a x chimera 
(see Figs. 2 and 3 for the A C activity in cells transfected with 
chimeras). However, similar increases in basal effector activity 
have been reported for comparable Gaq/(Xj chimeras [7]. CTX-
stimulated values of c A M P formation were severalfold higher 
than these elevated basal activities, allowing for further stim-
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Fig. 1. Construction and expression of the Ga s chimeras. Con-
structed Ga s /ax and their C-terminal 5 residues are illustrated in 
(A). Gocs wt represents wild-type Goi,. (B) Expression of the trans-
fected Goes chimeras. Cells were transfected with 3 ug/106 cells of ei-
ther Ga s chimera cDNA and expression of each corresponding 52-
kDa protein was analyzed by the standard immunoblotting with 
anti-common Ga antibody (Du Pont-NEN). Under the condition 
employed, the endogenous 45-kDa Ga s was neither detected. 
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ulation of AC in chimera-transfected cells in response to 
linked receptor stimulation. 
With SSTR3, we transfected chimeras derived from the Gi 
family and examined SST-dependent increase in cAMP. 
SSTR3 has been shown to be an AC-inhibiting receptor in 
various cell systems [16-20]. In our COS cells transfected 
with SSTR3, SST treatment resulted in significant inhibition 
of AC (Table 1), whereas SST did not suppress AC without 
receptor transfection (data not shown). As in the literature, 
SSTR3 thus acted as an AC-inhibitory receptor in our system. 
In contrast to the suppression of AC in cells expressing 
SSTR3 alone, SST paradoxically augmented AC activity in 
cells transfected with SSTR3 and Gocs/(Xi (Fig. 2A). Because 
no stimulation was induced by SST in cells transfected with 
any chimera alone (Fig. 2B), SSTR3 was responsible for this 
action of SST. In cells transfected with SSTR3 and either 
Gocs/a0 or Gas/az, no stimulation of AC was induced by 
SST (Fig. 2A). We previously showed that our Gas/aD is a 
functional construct because this chimera augmented cAMP 
activity in response to a stimulated G0-coupled receptor [12]. 
The Gocs/ocz construct was also functional because SST stim-
ulation augmented AC activity when Gocs/az was co-expressed 
with SSTR1 (Fig. 2C). Since only two or three residues, out of 
394, are different between Gas/oc; and Gocs/a0 or GOs/az (Fig. 
1A), our data suggest that SSTR3 has an extremely selective 
potency to discriminate G(Xi against other members of the Gi 
family. 
We thus conclude that SSTR3 recognizes the C-terminus of 
Got; but not of either Goto or Gocz, suggesting that SSTR3 
inhibits AC through GoCi, not through Gcx0 or Gaz. This is 
partly consistent with the study of Murray-Whelan and Schle-
gel [21] arguing for a lack of SSTR association with Ga0 in 
the brain, although the involved SSTR subtype was not speci-
fied by their study. The possibility is remote that in Gas/a;-
expressing cells, SSTR3 activates endogenous Gi and the re-
leased G(3y promotes AC activity, because (i) G|3y requires the 
elevated Gots activity to stimulate AC [22]; (ii) Gocs/oc0 and 
Gocs/ccz exhibited basal Gocs activities as high as those of Gocs/ 
a; chimeras; and (iii) co-expression of GaJaQ or Gocs/az did 
not assist SSTR3 stimulation of AC. Thus, AC activation by 
SST should be through the direct activation of Gccs/(Xi by 
SSTR3. 
Whether the coupling of SSTR3 to other Got family could 
be predicted by our chimeras? We co-transfected SSTR3 with 
either of Gas/ocq, Gas/oci2, Gas/oc^, Gas/ai4 , or Gas/ai6 and 
measured AC activity in response to SST in a similar manner. 
In cells expressing SSTR3 and either Gas/oci4 or Gas/oci6, SST 
significantly stimulated AC (Fig. 3A). In contrast, in cells 
expressing SSTR3 and Gcxs/ocq, no stimulation of AC was 
induced by SST (Fig. 3A). This was also the case with Gocs/ 
cci2 or GOs/ai3 (the AC activity in the presence of 1 uM SST 
was 72.6 ±6.2% or 92.9 ±5.0% of AC activity in the absence 
of SST, respectively). Either of Gocs/aq, Gas/ai2 or Gocs/ai3 
was expressed to the extent comparable to those of Gocs/ai4 
and GOs/a16 under the conditions employed (Fig. IB). Again, 
no stimulation was observed without SSTR3 transfection 
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(Fig. 3B), confirming the involvement of SSTR3 in the acti-
vation of Gocs/(Xi4 or Gas/oci6. Although the observed SST-
induced increase in A C might be small in quantity, this aug-
mentat ion was statistically significant. Note that SST reduced 
c A M P formation when SSTR3 was transfected without Gots/ 
(Xi4 or GcCs/ai6. Therefore, the net effect of SSTR3 on these 
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Table 1 
SSTR3 is 
C T X -
CTX+ 
coupled 
SST-
0.73 
25.9 
to AC 
±0.05 
±1.9 
suppression in an SST-dependent 
SST+ 
0.58 ±0.02* 
18.9 ±0.4* 
manner 
Effects of SST on basal and CTX (cholera toxin)-stimulated forma-
tion of cAMP in SSTR3-transfected cells. Cells were transfected with 
0.125 ug SSTR3 DNA, as described in Section 2. Forty-eight hours 
after transfection, cells were treated for 30 min with or without 1 u,M 
SST in the presence of 1 mM IBMX with or without 250 ng/ml CTX, 
and cAMP formation was measured and indicated as cAMP/ 
(ADP+ATP)X103. All values are means ±SE of four independent 
transfections. 
*P<0.05 vs. no SST. 
chimeras was larger than what the percent increase of the SST 
effect represented. We thus considered statistically significant 
effects in this assay as positive. 
However, Lee et al. [23] constructed chimeras consisting of 
G a n and Goii6 and found that the C-terminal 155 residues of 
Goci6, particularly residues 220-240, are required to confer 
C5a-induced activation of G a n . In contrast, our data suggest 
that the C-terminal 5 residues of Gai6 may confer efficient 
SSTR3 coupling to Ga s . For this reason, we repeated the Gq 
family chimera experiments in a way different from that just 
described, and performed quantitative comparison. In Fig. 
3C, various chimeras derived from the G; and Gq family 
were simultaneously tested in the presence of SSTR3 expres-
sion. The SST-dependent fold increase of either chimera ac-
tivity was totally reproducible, in terms of the stimulation 
quantity as well as the relative ratio between the G and Gq 
families (Fig. 3C). These data confirm the coupling of SSTR3 
to Gas/ai4 and Gas/ai6. The discrepancy from the study of 
Lee et al. [23] suggests that some other portions in Gai6, 
conserved by Ga s but not by G a n , are also required for 
efficient coupling to receptors. 
PLC (phospholipase C) stimulation is the established, spe-
cific output of the Gq family (Ga q / n , G a ^ , Ga^ ) . We next 
examined whether SSTR3 can activate PLC through intact 
Ga of this family. When both Gai6 and SSTR3 were ex-
pressed in COS cells, SST robustly augmented IP (inositol 
phosphate) production (Fig. 4A). Single expression of either 
gene (Gai6 or SSTR3) did not allow SST to stimulate PI 
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turnover. Consistent with the PTX resistance of Gai6, PTX 
failed to affect this stimulation (Fig. 4A), confirming that 
SSTR3-induced PI turnover is mediated by the transfected 
Goei6 and not by G|fy derived from endogenous G;. Positive 
coupling with intact Ga was also the case with Gcci4. 
Although the coupling between SSTR3 and G044 seemed 
less efficient than that between SSTR3 and G046, the effect 
of SST was significant in cells co-expressing SSTR3 and Gctu 
(Fig. 4B). Supporting the validity of the prediction by the 
chimeras, this observation suggests that certain N-terminal 
regions in Goiu are also required for its effective receptor 
coupling. 
In contrast, SST had no effect on IP production in cells 
expressing SSTR3 with Gocq (Fig. 4C). Transfection of 
PTHR cDNA with or without Ga q resulted in significant 
stimulation of IP production in response to 1 uM PTH 1-
34 (Fig. 4D). Transfection of Gocq further augmented the effi-
cacy of PTHR to activate PLC activity. These observations 
are consistent with the reports that (i) PTHR causes PI turn-
over in a PTX-insensitive manner [24] and (ii) COS cells en-
dogenously express Gaq and Gotn [25]. Note that the PTHR/ 
Gaq-induced PLC activity was exceeded by SSTR3/Goci6 -in-
duced activity, indicating that SSTR3 coupling to Gai6 was 
more than or equally as efficient as the PTHR-Gaq coupling. 
Taken together, our data indicate that SSTR3 specifically 
couples to non-Gaq members of the Gq family and induces 
PI turnover in intact cells. 
We have shown herein that SSTR3 recognizes the C-termi-
nus of Ga; but not of Ga 0 or Gaz . Although the C-terminal 
recognition of Ga; by SSTR3 was expected by previous stud-
ies, inability of SSTR3 to recognize the C-termini of Ga0 and 
Gocz was unexpected, as they are extremely homologous. No 
receptors have so far coupled to Ga without recognizing its 
C-terminus [7-9]. Therefore, the present study indicates that 
SSTR3 has no molecular function to directly recognize Ga0 
or Ga z ; thus, it inhibits AC through G; but not through G0 
or Gz. 
The chimeric Ga s system also served as an essential probe 
in further characterizing the G-protein-coupling function of 
SSTR3. It is shown here that SSTR3 directly couples to 
Gai4 and Gai6, but not to Gaq . Until this study, little has 
been known about the coupling of this receptor with these Gq 
subclass of G-proteins. In theory, this approach can be ap-
plied to unlimited numbers of G-coupled receptors, including 
both muti-spanning and single-spanning ones. We however 
emphasize that the C-terminal residues of Ga may not be 
the sole site for receptor contact, although they are necessary 
[7]. Therefore, positive data from our chimeras may not al-
ways signify the coupling to intact G-proteins, while negative 
data are able to exclude it. This notion is consistent with the 
report of Law et al. [19] showing that SSTR3 selectively cou-
ples to Gaii but not Ga;2 in CHO cells, despite the identical 
C-termini of these Ga. The observed quantitative difference of 
SSTR3 coupling between Gai4 and Gai6 also supports this 
idea. 
The precise assignment of G-proteins linked to a given re-
ceptor has been very difficult. Among several approaches aim-
ing at the assessment of the involved G-proteins in receptor 
signals, including those with antibodies for and peptides of 
Ga, only the approach with microinjection of anti-sense oli-
gonucleotides has been successful [26]. However, there are 
critical limitations in that approach; for instance, that is 
only applicable to cellular responses detectable in a single 
cell. Our present study proposes a more accessible and com-
prehensive approach for the assignment of G-proteins coupled 
to any given receptor. 
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